Skip to Content
MayoACCESS
MayoLINK
Register
My Dashboard
Test Catalog
Algorithms
Download Test Catalog & Interpretive Handbook
New Tests
NY State Informed Consent Tests
Performing Locations
Referred Tests
Specialty Testing
Test Updates
Ordering & Results
Critical Values & Results
Custom Gene Ordering
Forms
LIS Resources
MayoACCESS Resources
MayoLINK Resources
Order Your First Test
Patient Information and Signature Forms
Request Additional Testing
Send Additional Specimen
Specimen Handling
Collection & Preparation
Dangerous Goods Training
Shipping & Courier Guides
Shipping Regulations
Supplies
Customer Service
Billing
Contact Us
FAQ
IT Updates
Joint Test Catalog Admin Resources
Operational Updates
Quality & Compliance
Education & Insights
Educational Resources
News
Outreach
Podcasts
Stories
Contact
Log Out
Return to Answers From the Lab
Coagulopathies and COVID-19: Nahla Heikal, M.D.
By
Melissa Peterson
•
October 27, 2020
Share this:
Related Episodes
Breakthrough Test Enhances Peripheral Neuropathy Care and Research
By
Samantha Rossi
•
March 5, 2026
How Strategic Collaborations Transform Clinical Diagnostics
By
Samantha Rossi
•
February 19, 2026
Innovation and Resilience in Lab Logistics
By
Sarah Jarvis
•
February 5, 2026
Melissa Peterson
Related Posts
Dr. Bill Morice shares the elements of an effective innovation strategy
Breakthrough Test Enhances Peripheral Neuropathy Care and Research
Precision epilepsy testing
